🔥 Today's Report: JNJ - Johnson & Johnson

Discover the Potential: Stock Report of the Day - Johnson & Johnson (NYSE:JNJ) Awaits! Amazon heads into February's earnings range-bound and seemingly asleep, forcing investors to choose between betting on a catch-up play or waiting for clarity.
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Stock of the Day
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson
JNJ 90-day price performance

Current Price

$218.09
-0.57 (-0.26%)
(As of 03:59 PM ET)
30 Day Performance
 
  
 
+5.62%
90 Day Performance
 
  
 
+13.11%
1 Year Performance
 
  
 
+48.33%

Market Capitalization

$525.44B

P/E Ratio

21.05

Dividend Yield

2.38%

About Johnson & Johnson

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world. The company's pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology,... Read Full Profile ▷

JNJ Company Calendar

Recent Johnson & Johnson News

Tue. January 20, 2026 4:29 PM EST | msn.com
CAPLYTA Shows Stronger Remission Results in Phase 3 MDD Data, JNJ Says
Tue. January 20, 2026 4:29 PM EST | msn.com
Johnson & Johnson Q4 preview: Strength in core portfolio keeps analysts bullish
Tue. January 20, 2026 4:29 PM EST | msn.com
Robotic surgery fuels Johnson & Johnson dividend growth outlook
Tue. January 20, 2026 2:09 PM EST | marketbeat.com
Healthcare Stocks To Follow Now - January 20th
Tue. January 20, 2026 12:11 PM EST | insidermonkey.com
Jim Cramer Says He Was Wrong for Selling Johnson & Johnson for the Charitable Trust

Top Stock News for Tuesday, January 20th

Refund From 1933: Trump's Reset May Create Instant Wealth (Ad)

Refund From 1933: Trump's Reset May Create Instant Wealth

Trump's Reset Can Give Birth To America's Greatest Era Yet

A 90-Year cycle may end soon, creating real wealth for early adopters

In 1933, Executive Order 6102 forced everyday Americans to hand over their gold at a fixed rate.

Everyday citizens lost a sizable amount of their hard earned wealth at the stroke of FDR's pen.tc pixel

Claim Your FREE Guide Now and discover how to position yourself for this golden opportunity. ▷

2 Ways to Trade Amazon Ahead of Earnings

Amazon-branded package carried by a delivery drone inside a warehouse, highlighting Amazon logistics and tech momentum.

Amazon heads into February's earnings range-bound and seemingly asleep, forcing investors to choose between betting on a catch-up play or waiting for clarity.

Read The Full Story ▷

Sea, Space, & Sky: 3 Frontier Robotics Stocks Under $20

Autonomous rover with robotic arm on a dusty desert-like terrain, symbolizing frontier robotics in harsh environments.

Frontier robotics stocks are capturing investor attention as they transition from research concepts to essential infrastructure for space and defense economies.

Read The Full Story ▷

Market Legend Reveals #1 Stock for 2026 (Ad)

Market Legend Reveals #1 Stock for 2026

A former billion-dollar hedge fund manager is revealing his number one stock to trade for 2026 plus an over-the-shoulder demo of the exact strategy that delivered 20 straight winning years for his clients. His system closed 12 winning positions in the first 12 weeks of 2025 and finished the year with an 85 percent win rate, including gains of 58 percent in a single day. For a limited time, you can access his One Ticker Trader service for $19 instead of the usual $499, backed by a 30-day money back guarantee.tc pixel

Watch the free demo and see how the strategy works. ▷

Rocket Lab Gets a Big Upgrade: Will Upside Follow?

Rocket Lab Electron rocket lifts off from coastal pad, plume and smoke rising beside Rocket Lab logo.

Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.

Read The Full Story ▷

Moderna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?

Moderna logo on frosted lab panel with biotech equipment, reflecting vaccine maker's stock rebound.

COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, down +90% from its all-time high?

Read The Full Story ▷

Your Bank Account Is No Longer Safe (Ad)

Your Bank Account Is No Longer Safe

What If Washington Declared That: YOUR Money ISN'T Actually Yours?

Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property.

What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.tc pixel

Get your free guide now by clicking here >> ▷

AMD Rebound Begins: It's Not Too Late to Get In

AMD logo centered on a futuristic circuit-board background with soft blue and red glow accents.

Advanced Micro Devices' rebound is underway and about to gain momentum as outperformance, guidance, and the expected launch of MI450 GPUs drive sentiment.

Read The Full Story ▷

Post a Comment

Previous Post Next Post

Contact Form